SCHEMBL32688189

SCHEMBL32688189

COC(=O)CSc1[nH]c(=O)cc(-c2cccc(C(=O)O)c2)c1C#N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.53
▸ HPGD P15428 6/20 0.53
▸ KMT2A Q03164 5/20 0.53
▸ POLB P06746 2/20 0.48
▸ MAPT P10636 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ ALOX15 P16050 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.46
▸ LMNA P02545 2/20 0.45
▸ KDM4E B2RXH2 3/20 0.43
▸ PKM P14618 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688277 0.89 KMT2A (0.52) ALDH1A1HPGDKMT2APOLBMAPT
SCHEMBL32688012 0.86 ACMSD (0.49) ALDH1A1HPGDKMT2APOLBMEN1
SCHEMBL32688306 0.84 KMT2A (0.59) ALDH1A1HPGDKMT2APOLBMEN1
SCHEMBL20339967 0.78 ACMSD (0.58) ALDH1A1HPGDKMT2APOLBMEN1
SCHEMBL20350857 0.78 ACMSD (0.56) ALDH1A1HPGDKMT2APOLBMEN1
SCHEMBL32688364 0.78 KMT2A (0.51) ALDH1A1HPGDKMT2APOLBMAPT
SCHEMBL20340172 0.78 ACMSD (0.61) ALDH1A1HPGDKMT2APOLBMEN1
SCHEMBL32688247 0.77 ACMSD (0.44) ALDH1A1HPGDKMT2AACMSDIKBKB
SCHEMBL26404201 0.77 TSHR (0.74) ALDH1A1HPGDKMT2APOLBMAPT
SCHEMBL20339939 0.77 KMT2A (0.62) ALDH1A1HPGDKMT2APOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885HPGD 431/4885KMT2A 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback